Genetic screening of Fabry patients with EcoTILLING and HRM technology
<p>Abstract</p> <p>Background</p> <p>Anderson-Fabry disease (FD) is caused by a deficit of the α-galactosidase A enzyme which leads to the accumulation of complex sphingolipids, especially globotriaosylceramide (Gb3), in all the cells of the body, causing the onset of a...
Main Authors: | Iemolo Francesco, Francofonte Daniele, Zizzo Carmela, Albeggiani Giuseppe, Nuzzo Domenico, Bono Caterina, Sanzaro Enzo, Duro Giovanni |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-09-01
|
Series: | BMC Research Notes |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1756-0500/4/323 |
Similar Items
-
Senza una multidisciplinarietà organizzata
by: Roberto Fanelli, et al.
Published: (2017-09-01) -
Cognitive impairment and Fabry Disease: a case report with mutation S126G
by: Razza, Grazia, et al.
Published: (2016-11-01) -
Increased prevalence of peripheral vestibular disorder among patients with Fabry disease
by: Tzong-Hann Yang, et al.
Published: (2024-03-01) -
NEUROLOGICAL MANIFESTATIONS OF FABRY DISEASE IN CHILDREN AND ADOLESCENTS
by: A. S. Kotov, et al.
Published: (2017-12-01) -
Role of standard echocardiography in Anderson–Fabry disease
by: Maddalena Conte, et al.
Published: (2024-10-01)